Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uterine artery embolization versus myomectomy: a multicenter comparative study.

Scott C Goodwin1, Linda D Bradley, John C Lipman

  • 1Department of Veterans Affairs, The University of California, Los Angeles, California, USA. scott.goodwin@med.va.gov

Fertility and Sterility
|January 18, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of gastric residual volume measured by nasogastric feeding tubes for management of dogs and cats after gastrointestinal foreign body surgery: a retrospective study.

Frontiers in veterinary science·2026
Same author

Infertility and age of menopause in a longitudinal cohort of women with primary infertility.

Menopause (New York, N.Y.)·2026
Same author

Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.

The New England journal of medicine·2026
Same author

Long-Term Outcomes of Uterine Artery Embolization for Treatment of Fibroids in Women Under 40: A Retrospective Survey Study at Two Institutions with Median 16-year Follow-up.

Cardiovascular and interventional radiology·2026
Same author

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Cancers·2026
Same author

Targeting the p53 pathway to treat atypical teratoid rhabdoid tumors.

Neuro-oncology pediatrics·2026

Uterine artery embolization (UAE) and myomectomy both improve quality of life for uterine fibroid patients. UAE offers faster recovery, shorter hospital stays, and fewer adverse events compared to myomectomy.

Area of Science:

  • Reproductive Medicine
  • Minimally Invasive Surgery
  • Gynecologic Surgery

Background:

  • Uterine fibroids significantly impact women's quality of life.
  • Surgical options like myomectomy and uterine artery embolization (UAE) are available for treatment.
  • Comparative data on patient outcomes and quality of life is crucial for informed decision-making.

Purpose of the Study:

  • To assess quality of life improvements after UAE.
  • To compare the outcomes of UAE and myomectomy for uterine fibroids.
  • To evaluate differences in recovery, hospital stay, and adverse events between the two procedures.

Main Methods:

  • Prospective cohort controlled study conducted across sixteen US medical centers.
  • 149 patients underwent UAE, and 60 patients underwent myomectomy, with treatment decisions based on physician and patient consensus.

Related Experiment Videos

  • Outcomes measured included quality of life scores, menstrual bleeding, uterine volume, time to recovery, and adverse events over 6 months to 1 year follow-up.

    • Main Results:

    • Both UAE and myomectomy groups showed significant improvements in quality of life, menstrual bleeding, and uterine volume.
    • UAE patients experienced shorter hospital stays (1 day vs. 2.5 days) and quicker return to normal activities (15 days vs. 44 days) and work (10 days vs. 37 days).
    • Adverse events were less frequent in the UAE group (22.1%) compared to the myomectomy group (40.1%).

    Conclusions:

    • Both UAE and myomectomy lead to significant improvements in quality of life for women with uterine fibroids.
    • No significant differences were found in the degree of improvement in bleeding, uterine volume, or quality of life scores between the two procedures.
    • UAE is associated with advantages in terms of reduced recovery time, shorter hospital stays, and a lower incidence of adverse events.